30 September 2021 - The U.S. House Judiciary Committee voted Thursday to approve a fourth bill aimed at tackling high drug prices, approving a measure that would make it easier for biosimilar drugs, cheaper versions of expensive biotech drugs, to come to market.

The same panel voted Wednesday to send three related bills to the House floor for consideration.

Read Reuters article